コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 GTPase (membrane anchored via its C-terminal geranylgeranylation).
2 can be modified in vitro by farnesylation or geranylgeranylation.
3 lysine region are important determinants for geranylgeranylation.
4 ed, all other gamma subunits are modified by geranylgeranylation.
5 not due to failure of the mutant to undergo geranylgeranylation.
6 ce on one mevalonate pathway output, protein geranylgeranylation.
7 signals via mevalonate metabolism to protein geranylgeranylation.
8 ), which is post-translationally modified by geranylgeranylation.
9 y provide valuable reagents to study protein geranylgeranylation.
10 ve DAF expression is negatively regulated by geranylgeranylation.
11 t affected by substituting farnesylation for geranylgeranylation.
12 vents seem to be downstream of inhibition of geranylgeranylation.
13 protein prenylation as shown by protein RhoA geranylgeranylation.
14 escribed Rho family proteins are modified by geranylgeranylation, a lipid attachment required for pro
17 lonate pathway, is the substrate for protein geranylgeranylation, a protein post-translational modifi
18 gh binding of Cdc42 to PLD1 does not require geranylgeranylation, activation of PLD1 is dependent on
20 errogating biologies associated with protein geranylgeranylation and define a novel structure for thi
21 n of the TRQQKRP motif results in diminished geranylgeranylation and delocalization of intracellular
24 talyzed farnesylation is 37-fold slower than geranylgeranylation and is limited by the farnesyl trans
26 ered with angiogenesis via inhibition of the geranylgeranylation and membrane localization of RhoA.
27 ough lovastatin, which inhibits both protein geranylgeranylation and protein farnesylation, blocked P
28 Our data indicate that inhibition of protein geranylgeranylation and RhoA pathways induce apoptosis i
30 ndent post-translational lipid modification (geranylgeranylation) and subsequent membrane association
31 ins simultaneously inhibit farnesylation and geranylgeranylation, and in consequence do not inhibit M
32 hich inhibits both protein farnesylation and geranylgeranylation, arrested cells in G0/G1 whereas cel
33 by geranylgeranyl pyrophosphate, implicating geranylgeranylation as a critical determinant of the sta
34 corresponding isoprenols, abolishes protein geranylgeranylation as well as GGOH-induced ERAD of redu
36 on tendon cell expansion is specific to the geranylgeranylation branch of the mevalonate pathway and
37 or tyrosine phosphorylation requires protein geranylgeranylation but not protein farnesylation and th
39 atin inhibits both protein farnesylation and geranylgeranylation by decreasing cellular pools of farn
40 ulation of iNOS by statins via inhibition of geranylgeranylation by GGTI-298, but not via inhibition
41 d with the C-terminal peptide of lamin B for geranylgeranylation by PGGT-I and for farnesylation by P
42 lation of leucine-ending CAAX substrates nor geranylgeranylation by the FTase is necessary for these
46 phosphate, we demonstrate that the impact of geranylgeranylation depends on the fatty acid content of
54 rdial cell-autonomous requirement of Ggamma1 geranylgeranylation for heart formation and suggest the
58 ause we have shown that targeting Rab GTPase geranylgeranylation impairs monoclonal protein trafficki
62 n, O-cholesterylation, S-farnesylation and S-geranylgeranylation in multiple cell lines to illustrate
63 tional lipid modifications farnesylation and geranylgeranylation in protein localization and function
65 These findings highlight the importance of geranylgeranylation in the dynamic management of RhoGTPa
66 Rap 1A; the lack of Rap 1A processing beyond geranylgeranylation in the variant cells was not seconda
68 s of protein prenylation and unique roles of geranylgeranylation in thymic egress and highlight that
69 y we demonstrated that inhibition of protein geranylgeranylation inhibited phorbol ester-stimulated a
70 further mutated to undergo posttranslational geranylgeranylation is also more active, recovering most
73 In this study, I show that the kinetics of geranylgeranylation is influenced by the nucleotide stat
77 lational modification of the Rho proteins by geranylgeranylation is required for their subsequent act
78 Prenylation of protein (farnesylation and geranylgeranylation) is involved in several human cancer
79 n addition to bypassing FTI blockade through geranylgeranylation, K-Ras4B resistance to FTIs may also
80 H 3T3 and Rat-1 cells) inhibition of protein geranylgeranylation leads to a G0/G1 arrest, whereas inh
81 anylgeranylated and that inhibition of their geranylgeranylation mediates, at least in part, the effe
82 able which can distinguish farnesylation and geranylgeranylation modification in a single experimenta
83 ne) while showing little preference for CAAL geranylgeranylation motif substrates (where L represents
84 pene blocks an MEP pathway-dependent protein geranylgeranylation necessary for the signaling cascade.
85 nesol, further confirming that inhibition of geranylgeranylation, not farnesylation, is responsible f
90 y low rate, suggesting that the low level of geranylgeranylation of GST-lHDAg observed in cytosolic p
95 an enzyme responsible for post-translational geranylgeranylation of Rab GTPases represents one way to
96 l blocked the ability of insulin to increase geranylgeranylation of Rab-4, whereas GGTI-298 and alpha
97 n cognate to Ras Gln-61.2) Posttranslational geranylgeranylation of Rab24, determined by metabolic la
99 where the inhibitors were shown to block the geranylgeranylation of Rap-1A without affecting the farn
100 geranyl pyrophosphate, the substrate for the geranylgeranylation of Rho, reversed the effect of simva
101 hibited by GGTI, a specific inhibitor of the geranylgeranylation of Rho; by C3 exotoxin, which inacti
104 e (100 micromol/L), suggesting inhibition of geranylgeranylation of target protein(s) as the predomin
105 -lowering drug that blocks farnesylation and geranylgeranylation of target proteins, increases LPS-in
109 mma1 CaaX sequence (gamma1-S74L) resulted in geranylgeranylation of the resulting gamma1 subunit, and
111 n requires a posttranslational modification, geranylgeranylation, of the C-terminal cysteine residue.
112 ies addressing which isoprenylation pathway--geranylgeranylation or farnesylation--is inhibited by si
115 e pharmacological shunting of K-Ras into the geranylgeranylation pathway promotes K-Ras association w
119 hese results document that farnesylation and geranylgeranylation play differential roles in AD pathog
120 presence of lovastatin, to stimulate protein geranylgeranylation, prevented lovastatin's effects.
121 e found that by supplying more substrate for geranylgeranylation, Rac1 activation was substantially i
123 om dissociating from REP prior to the second geranylgeranylation reaction, ensuring efficient digeran
124 Third, we show that free REP inhibits the geranylgeranylation reaction, suggesting that the comple
126 However, the catalytic efficiencies of these geranylgeranylation reactions are between 15- and 140-fo
129 ermine whether protein prenylation (farnesyl/geranylgeranylation) regulates matrix metalloproteinase
139 1 or Sso2 proteins that have a COOH-terminal geranylgeranylation signal instead of a transmembrane do
140 fect resulted from the inhibition of protein geranylgeranylation subsequent to the depletion of meval
141 gin have higher levels of proteins requiring geranylgeranylation than arterial endothelial cells and
143 gh the classical Rho GTPases are modified by geranylgeranylation, we found that a majority of the oth
144 potentiate the induced-inhibition of protein geranylgeranylation when used in a 3:1 HG:HN combination
145 synthesis, which blocks cytokinesis, and in geranylgeranylation, which interferes with progression t
146 up-regulate eNOS expression by blocking Rho geranylgeranylation, which is necessary for its membrane
147 is caused by lipid depletion limits RAB-11.1 geranylgeranylation, which promotes nuclear translocatio
148 ts as a highly specific inhibitor of protein geranylgeranylation, while 3-vinylgeranylgeraniol restor